National Institute of Allergy and Infectious Diseases (NIAID): Autoimmune Diseases trials
The registry lists 16 Autoimmune Diseases studies with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor. 7 are open to participants now and 3 have results posted.
Early Phase 1 1Phase 1 4Phase 2 4Phase 3 1No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Ublituximab in Autoantibody Positive Immune Mediated Necrotizing MyopathyRecruitingNCT07103746Phase 2
- Daratumumab in Primary Antiphospholipid SyndromeRecruitingNCT05671757Phase 1/2
- Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)RecruitingNCT04097561Phase 1
- NIAID Centralized Sequencing ProtocolRecruitingNCT03206099
- Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ LymphocytopeniaRecruitingNCT00867269
- Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell DeathRecruitingNCT00246857
- Study of Autoimmune Lymphoproliferative Syndrome (ALPS)RecruitingNCT00001350
- COVID-19 Booster Vaccine in Autoimmune Disease Non-RespondersTerminatedNCT05000216Phase 2Results posted
- A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)TerminatedNCT01489956Early Phase 1Results posted
- Scleroderma: Cyclophosphamide or TransplantationCompletedNCT00114530Phase 2/3Results posted
- T and B Cell Responses in Autoimmune DiseasesTerminatedNCT01947036
- Collection of Blood, Bone Marrow, Leukapheresis, and Tissue Biopsy Samples From Patients and Their Family Members for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases Laboratory Research StudiesTerminatedNCT01200823
- Screening Protocol for Genetic Diseases of Allergic InflammationCompletedNCT00852943
- Pyrimethamine to Treat Autoimmune Lymphoproliferative SyndromeCompletedNCT00065390Phase 1
- Treatment of Multiple Sclerosis With Copaxone and AlbuterolCompletedNCT00039988Not applicable
- Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative SyndromeCompletedNCT00013689Phase 1